NEWPORT BEACH, CA -- (Marketwire) -- 03/12/13 -- Dr. Nancy Silverberg, a board-certified Newport Beach dermatologist, is excited to offer the patients of Silverberg Surgical & Medical a new treatment for wrinkles. LaViv (azficel-T) is an innovative therapy that utilizes the patient's own collagen-producing cells to reduce the appearance of facial lines.
Dr. Silverberg has played an integral role in the evolution and testing of LaViv. Tested in Europe and the U.S where the product's effectiveness and safety were established, she served as a member of the investigative team for its clinical trials. The resulting data has taken ten years to collect and Dr. Silverberg and her team members recently celebrated the FDA's approval for LaViv. Fibrocell Sciences is now in the final stages of making this new treatment widely available.
According to Dr. Silverberg, the biggest advantage of LaViv cell therapy is that the process uses the patient's own cells rather than a synthetic or foreign agent. LaViv is a much more natural option than most other wrinkle treatments. In a process developed by Fibrocell Sciences, LaViv reproduces the patient's own natural collagen-producing cells (also called fibroblasts) in a certified laboratory and then injects the new cells into the treatment area. These cells are grown from a small sample of tissue taken from behind the patient's ear.
After the patient's initial visit, it takes about 6-8 weeks for the new cells to reproduce and be returned to the doctor's office. When the patient returns for the second visit, Dr. Silverberg injects the cells into the patient using a clinically proven sterile method. In addition, Fibrocell Sciences is able to store any unused cells for future treatments.
According to the clinical data, LaViv patients experience long-lasting results from the procedure. Some of the trial patients who participated in LaViv studies 10 years ago are still experiencing positive results.
Fibrocell Sciences has chosen Dr. Silverberg to teach fellow dermatologists and plastic surgeons how to administer LaViv cell therapy. Having completed Fibrocell Science's Education & Certification Program certifying her as an instructor, Dr. Silverberg is proud to be a leader in this revolutionary wrinkle treatment technique and offer her Newport Beach dermatology patients a more natural method of skin rejuvenation that is becoming an important part of Silverberg Surgical & Medical Group's anti-aging armamentarium.
More information about LaViv can be found on Dr. Silverberg's blog post entitled, "LaViv Q&A with Dr. Nancy Silverberg."
About Nancy Lee Silverberg, MD
Dr. Nancy Silverberg is a graduate of Cornell University and earned her medical degree at the St. Louis University School of Medicine. She is a board-certified dermatologist and currently serves as Associate Clinical Professor of Dermatology at the University of California, Irvine. Specializing in cosmetic dermatology and Mohs micrographic surgery for skin cancer, Dr. Silverberg is a Fellow of the American Society for Mohs Surgery. She is available for interview upon request.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2253784
Add to Digg Bookmark with del.icio.us Add to Newsvine
Silverberg Surgical & Medical Group
1401 Avocado Ave
Newport Beach, CA 92660
Most Popular Stories
- Schedule packed with talent at the Fox
- I never set out to be a role model but it's great to be one ; IN THE HOTSEATBetter known by his stage name Wretch 32, Jermaine Sinclair is a 28-year-old rapper from London. In 2011 his debut album Black and White sold over a million copies and scored three top five singles. His latest single Blackout was released this week
- Entrepreneurs Chase Social Media
- European Car Sales up First Time in 20 Months
- Promoter McLean 'provided more musical joy than Dylan and Prince combined'
- Emirati announces new film project at Cannes
- The Blade, Toledo, Ohio, TK Barger column
- SINCE YOU ASKED [Pittsburgh Tribune-Review (PA)]
- SET PHASERS TO DUMB Spock emotional and in love? Nonstop explosions? The highly illogical enterprise of J.J. Abrams' 'Star Trek'
- Detroit Free Press Julie Hinds column